Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "KarMMa-3 Trial - Ide-Cel vs. Standard Regimens in Patients With Triple-Class-Exposed R/R MM"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Krina Patel
By
Insights from 2023 ASH Annual Meeting
FEATURING
Krina Patel
Login to view comments.
Click here to Login